These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8497811)

  • 1. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
    Hudson CJ; Young LT; Li PP; Warsh JJ
    Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on neuroreceptor mechanisms and their implication for the pharmacotherapy of affective disorders.
    Sulser F
    J Clin Psychiatry; 1986 Oct; 47 Suppl():13-20. PubMed ID: 3020011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affective disorders, antidepressant drugs and brain metabolism.
    Moretti A; Gorini A; Villa RF
    Mol Psychiatry; 2003 Sep; 8(9):773-85. PubMed ID: 12931205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS; Koppel J; Goldberg S
    Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA; Zhou R; Du J; Moore GJ; Manji HK
    J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implications of cAMP signaling in affective disorders].
    Pérez J; Tardito D
    Vertex; 2001; 12(43):21-6. PubMed ID: 11907588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
    Dilsaver SC
    J Clin Psychopharmacol; 1986 Apr; 6(2):65-74. PubMed ID: 3517080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders.
    Cleary C; Linde JA; Hiscock KM; Hadas I; Belmaker RH; Agam G; Flaisher-Grinberg S; Einat H
    Brain Res Bull; 2008 Jul; 76(5):469-73. PubMed ID: 18534253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment.
    Young LT; Bezchlibnyk YB; Chen B; Wang JF; MacQueen GM
    Biol Psychiatry; 2004 Mar; 55(6):570-7. PubMed ID: 15013825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a biaxial model of "bipolar" affective disorders: spectrum phenotypes as the products of neuroelectrical and neurochemical alterations.
    Askland K; Parsons M
    J Affect Disord; 2006 Aug; 94(1-3):15-33. PubMed ID: 16725206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major affective disorders and schizophrenia: a common molecular signature?
    Van Den Bogaert A; Del-Favero J; Van Broeckhoven C
    Hum Mutat; 2006 Sep; 27(9):833-53. PubMed ID: 16917879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of psychopharmacological revolutions.
    Healy D
    Psychiatr Dev; 1987; 5(4):349-76. PubMed ID: 3328200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in cAMP signal transduction function and gene expression related to the onset of affective disturbance--the relationship between stress, antidepressants and expression of BDNF mRNA].
    Morinobu S; Fujimaki Y; Takahashi M; Totsuka S
    Seishin Shinkeigaku Zasshi; 1996; 98(11):937-42; discussion 942-6. PubMed ID: 9102653
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical role of brain-derived neurotrophic factor in mood disorders.
    Hashimoto K; Shimizu E; Iyo M
    Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.